Lieberman David M, Jan Taha A, Ahmad S Omar, Most Sam P
Department of Otolaryngology-Head & Neck Surgery, Stanford University, 801 Welch Road, Stanford, CA 94305, USA.
Arch Facial Plast Surg. 2011 Mar-Apr;13(2):117-24. doi: 10.1001/archfacial.2010.98. Epub 2010 Nov 15.
To assess the effects of corticosteroid administration on functional recovery and cell survival in the facial motor nucleus (FMN) following crush injury in adult and juvenile mice and to evaluate the relationship between functional recovery and facial motoneuron survival.
A prospective blinded analysis of functional recovery and cell survival in the FMN after crush injury in juvenile and adult mice was carried out. All mice underwent a unilateral facial nerve crush injury and received 7 doses of daily injections. Adults received normal saline or low-dose or high-dose corticosteroid treatment. Juveniles received either normal saline or low-dose corticosteroid treatment. Whisker function was monitored to assess functional recovery. Stereologic analysis was performed to determine neuron and glial survival in the FMN following recovery.
Following facial nerve injury, all adult mice recovered fully, while juvenile mice recovered slower and incompletely. This corresponded to a significantly greater neuron loss in the FMN of juveniles compared with adults. Corticosteroid treatment slowed functional recovery in adult mice. This corresponded with significantly greater neuron loss in the FMN in corticosteroid-treated mice. In juvenile mice, corticosteroid treatment showed a trend, which was significant at several time points, toward a more robust functional recovery compared with controls.
Corticosteroid treatment slows functional recovery and impairs neuron survival following facial nerve crush injury in adult mice. The degree of motor neuron survival corresponds with functional status. In juvenile mice, crush injury results in overall poor functional recovery and profound cell loss in the FMN. With low-dose corticosteroid treatment, there is a significantly enhanced functional recovery after injury in these mice (P < .05).
评估皮质类固醇给药对成年和幼年小鼠面神经挤压伤后面部运动核(FMN)功能恢复和细胞存活的影响,并评估功能恢复与面神经运动神经元存活之间的关系。
对幼年和成年小鼠面神经挤压伤后FMN的功能恢复和细胞存活进行前瞻性盲法分析。所有小鼠均接受单侧面神经挤压伤,并接受7次每日注射。成年小鼠接受生理盐水、低剂量或高剂量皮质类固醇治疗。幼年小鼠接受生理盐水或低剂量皮质类固醇治疗。监测触须功能以评估功能恢复情况。在恢复后进行体视学分析以确定FMN中的神经元和神经胶质细胞存活情况。
面神经损伤后,所有成年小鼠均完全恢复,而幼年小鼠恢复较慢且不完全。这与幼年小鼠FMN中神经元损失明显多于成年小鼠相对应。皮质类固醇治疗减缓了成年小鼠的功能恢复。这与皮质类固醇治疗的小鼠FMN中神经元损失明显增加相对应。在幼年小鼠中,皮质类固醇治疗与对照组相比显示出一种趋势,即在几个时间点上功能恢复更强劲,这种趋势具有统计学意义。
皮质类固醇治疗减缓了成年小鼠面神经挤压伤后的功能恢复并损害了神经元存活。运动神经元存活程度与功能状态相对应。在幼年小鼠中,挤压伤导致FMN整体功能恢复不佳和严重的细胞损失。低剂量皮质类固醇治疗后,这些小鼠损伤后的功能恢复明显增强(P <.05)。